High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial

Abdel-Wahab, Mohamed; Richardt, Gert; Joachim Büttner, Heinz; Toelg, Ralph; Geist, Volker; Meinertz, Thomas; Schofer, Joachim; King, Lamin; Neumann, Franz-Josef; Khattab, Ahmed Aziz (2013). High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. JACC. Cardiovascular Interventions, 6(1), pp. 10-19. Elsevier 10.1016/j.jcin.2012.07.017

[img] Text
1-s2.0-S193687981201000X-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (645kB)

OBJECTIVES

This study sought to determine the effect of rotational atherectomy (RA) on drug-eluting stent (DES) effectiveness.

BACKGROUND

DES are frequently used in complex lesions, including calcified stenoses, which may challenge DES delivery, expansion, and effectiveness. RA can adequately modify calcified plaques and facilitate stent delivery and expansion. Its impact on DES effectiveness is widely unknown.

METHODS

The ROTAXUS (Rotational Atherectomy Prior to TAXUS Stent Treatment for Complex Native Coronary Artery Disease) study randomly assigned 240 patients with complex calcified native coronary lesions to RA followed by stenting (n = 120) or stenting without RA (n = 120, standard therapy group). Stenting was performed using a polymer-based slow-release paclitaxel-eluting stent. The primary endpoint was in-stent late lumen loss at 9 months. Secondary endpoints included angiographic and strategy success, binary restenosis, definite stent thrombosis, and major adverse cardiac events at 9 months.

RESULTS

Despite similar baseline characteristics, significantly more patients in the standard therapy group were crossed over (12.5% vs. 4.2%, p = 0.02), resulting in higher strategy success in the rotablation group (92.5% vs. 83.3%, p = 0.03). At 9 months, in-stent late lumen loss was higher in the rotablation group (0.44 ± 0.58 vs. 0.31 ± 0.52, p = 0.04), despite an initially higher acute lumen gain (1.56 ± 0.43 vs. 1.44 ± 0.49 mm, p = 0.01). In-stent binary restenosis (11.4% vs. 10.6%, p = 0.71), target lesion revascularization (11.7% vs. 12.5%, p = 0.84), definite stent thrombosis (0.8% vs. 0%, p = 1.0), and major adverse cardiac events (24.2% vs. 28.3%, p = 0.46) were similar in both groups.

CONCLUSIONS

Routine lesion preparation using RA did not reduce late lumen loss of DES at 9 months. Balloon dilation with only provisional rotablation remains the default strategy for complex calcified lesions before DES implantation.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Khattab, Ahmed Aziz

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1876-7605

Publisher:

Elsevier

Language:

English

Submitter:

Judith Liniger

Date Deposited:

16 Jun 2014 13:11

Last Modified:

05 Dec 2022 14:34

Publisher DOI:

10.1016/j.jcin.2012.07.017

PubMed ID:

23266232

Uncontrolled Keywords:

calcified lesions, drug-eluting stents, lesion preparation, rotablation, rotational atherectomy

BORIS DOI:

10.7892/boris.51856

URI:

https://boris.unibe.ch/id/eprint/51856

Actions (login required)

Edit item Edit item
Provide Feedback